Cancer stem cell-like cells from a single cell of oral squamous carcinoma cell lines. 
Resistance of oral squamous cell carcinomas (OSCC) to conventional chemotherapy or radiation therapy might be due to cancer stem cells (CSCs).  The development of novel anticancer drugs requires a simple method for the enrichment of CSCs.  CSCs can be enriched from OSCC cell lines, for example, after cultivation in serum-free cell culture medium (SFM).  In our study, we analyzed four OSCC cell lines for the presence of CSCs.  CSC-like cells could not be enriched with SFM.  However, cell lines obtained from holoclone colonies showed CSC-like properties such as a reduced rate of cell proliferation and a reduced sensitivity to Paclitaxel in comparison to cells from the parental lineage.  Moreover, these cell lines differentially expressed the CSC-marker CD133, which is also upregulated in OSCC tissues.  Interestingly, CD133(+) cells in OSCC tissues expressed little to no Ki67, the cell proliferation marker that also indicates reduced drug sensitivity.  Our study shows a method for the isolation of CSC-like cell lines from OSCC cell lines.  These CSC-like cell lines could be new targets for the development of anticancer drugs under in vitro conditions.